CSL312
Hereditary Angioedema
Phase 3Active
Key Facts
About CSL
CSL Limited is one of the world's largest biotechnology companies, specializing in plasma-derived therapies, vaccines, and innovative medicines. With a global presence spanning over 35 countries and employing more than 27,000 people, CSL has built a reputation for scientific excellence and operational expertise over more than a century. The company's diversified portfolio includes life-saving treatments for rare diseases, critical care medicines, and seasonal and pandemic vaccines.
View full company profileOther Hereditary Angioedema Drugs
| Drug | Company | Phase |
|---|---|---|
| Orladeyo | Royalty Pharma | Commercial |
| DAWNZERA (donidalorsen) | Ionis Pharmaceuticals | Phase 3 |